BLUEJET
Blue Jet Healthcare Limited (BLUEJET) Stock Analysis
Blue Jet Healthcare Limited is an Indian specialty chemicals and pharmaceutical intermediates company. It manufactures niche chemistries for global pharma and agrochemical customers. Export-oriented production supports international supply chains from India. The company is listed on Indian stock exchanges and operates from India.
Healthcare › Biotechnology
₹514.60
-5.02% 1W | -17.20% 52W
Market Cap
8.9k CR
P/E Ratio
38
52W High
₹692.9
52W Low
₹325
Div. Yield
0.23%
Beta
0.6
50 DMA
₹577.5
200 DMA
₹484.3
Profit Margin
26.5%
Inst. Own.
5.7%
✅ BOUNCE FROM SUPPORT
✅ BOUNCE FROM SUPPORT
Fundamentals
Profit & Loss
No profit & loss data available.
| Metric | Mar 2020 | Mar 2021 |
|---|---|---|
| Sales | 538 | 499 |
| Expenses | 324 | 293 |
| Operating Profit | 214 | 206 |
| OPM % | 40% | 41% |
| Other Income | 6 | 4 |
| Interest | 7 | 5 |
| Depreciation | 18 | 20 |
| Profit before tax | 194 | 185 |
| Tax % | 25% | 26% |
| Net Profit | 145 | 136 |
| EPS in Rs | 24,141.67 | 1,396.49 |
| Dividend Payout % | 0% | 0% |
Shareholding Pattern
Promoters79.81%
FIIs1.83%
DIIs3.63%
Public14.74%
Promoters79.81%
FIIs1.14%
DIIs4.65%
Public14.41%
Promoters79.81%
FIIs0.89%
DIIs4.51%
Public14.80%
Promoters79.81%
FIIs0.40%
DIIs4.65%
Public15.14%
Promoters73.15%
FIIs0.63%
DIIs9.11%
Public17.11%
Promoters86.00%
FIIs2.01%
DIIs3.04%
Public8.97%
Promoters86.00%
FIIs2.28%
DIIs1.33%
Public10.38%
Promoters79.81%
FIIs0.89%
DIIs4.51%
Public14.80%
Promoters73.15%
FIIs0.63%
DIIs9.11%
Public17.11%
BLUEJET
Holdings Analysis
Key strengths & risk signals
73
Overall
76
Fundamental
70
Technical
Risks (4)
NEGLIGIBLE DIVIDEND! 0.23% yield - little to no income.
RECOVERY MODE! Current price (514.6) above 200-day but below 50-day.
WEAK YEAR! Stock declined 17.2% in the last year.
NEGATIVE MOMENTUM! Price declined across timeframes - down 5.0% (1 week), 10.6% (1 month), 17.5% (3 months).
Strengths (4)
EXCELLENT EFFICIENCY! 26.5% profit margin - company keeps strong profits.
BULLISH TREND! 50-day average (577.5) is above 200-day average (484.3) - positive signal.
LOW VOLATILITY! Beta of 0.60 - stable stock, less market risk.
BULLISH SENTIMENT! In last 30 days: 11 up days, 19 down days. Avg volume on up days: 509,187 vs down days: 339,847. Ratio: 1.5x
Fundamental & Technical Analysis
73Overall
76Fundamental
70Technical
Fundamental Breakdown
Growth Quality
21/30
Revenue CAGR: 9.4% (MODERATE, 8/15). Profit CAGR: 15.7% (VERY GOOD, 13/15).
Profit Margin
9/10
EXCELLENT EFFICIENCY! 26.5% profit margin - company keeps strong profits.
PEG Valuation
7/10
OVERVALUED! PEG of 2.42 means expensive relative to growth rate.
Dividend Yield
3/10
NEGLIGIBLE DIVIDEND! 0.23% yield - little to no income.
Debt to Equity
10/10
VERY LOW DEBT! D/E of 0.02 - excellent financial health.
Public Holding
20/20
VERY LESS PUBLIC HOLDING! 7.37% public ownership - strong promoter/institutional control.
Stability Index
6/10
MODERATE STABILITY! 2 revenue dips in history. Acceptable but monitor closely.
Technical Breakdown
Moving Averages
12/10
BULLISH TREND! 50-day average (577.5) is above 200-day average (484.3) - positive signal.
Price Position
2/10
RECOVERY MODE! Current price (514.6) above 200-day but below 50-day.
Trend Pattern
16/20
TESTING SUPPORT! Stock is at key support level.
52W Performance
2/10
WEAK YEAR! Stock declined 17.2% in the last year.
Volume Sentiment
25/30
BULLISH SENTIMENT! In last 30 days: 11 up days, 19 down days. Avg volume on up days: 509,187 vs down days: 339,847. Ratio: 1.5x
RSI
4/5
APPROACHING OVERSOLD! RSI at 30.2 - watch for reversal.
52W Range
3/5
MID RANGE! Trading at 51.5% of 52W range - neutral zone.
Momentum
1/5
NEGATIVE MOMENTUM! Price declined across timeframes - down 5.0% (1 week), 10.6% (1 month), 17.5% (3 months).
Beta
5/5
LOW VOLATILITY! Beta of 0.60 - stable stock, less market risk.
BLUEJET
Concall / Investor Presentation
Earnings call transcripts & AI summaries
| Quarter | Concall | Summary |
|---|---|---|
| Q1FY272026-08-07 | Concall PDF | |
| Q4FY262026-05-29 | Concall PDF | |
| Q3FY262026-02-17 | Concall PDF | |
| Q2FY262025-11-08 | Concall PDF |
Peer Comparison
Healthcare · Biotechnology · 8 stocks
| Stock | Price | P/E | Profit Margin | Revenue CAGR 5Y | Profit CAGR 5Y | 52W Change | Stock Strength | Trendline | YoY Profit | QoQ Profit | YoY Revenue | QoQ Revenue |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| BLUEJET | ₹514.60 | 38 | 26.5% | 9.4% | 15.7% | -17.2% | 73 | BOUNCE FROM SUPPORT | -14.1% | +21.8% | -17.4% | +24.9% |
| SUPRIYA | ₹847.60 | 34.4 | 22.7% | 21.2% | 32.5% | +23.4% | 83 | BOUNCE FROM SUPPORT | -31.0% | -67.7% | +30.7% | -31.4% |
| CONCORDBIO | ₹1,361.40 | 46.9 | 24.8% | 8.0% | 2.8% | -15.2% | 58 | BOUNCE FROM SUPPORT | +30.8% | -35.0% | +26.2% | -21.0% |
| ONESOURCE | ₹1,461.30 | – | -3.1% | 232.4% | – | -18.3% | 44 | BREAKDOWN | -12,600.0% | +443.5% | +37.2% | +4.9% |
| ZOTA | ₹1,324.10 | – | -17.0% | 56.7% | – | -7.9% | 57 | CONSOLIDATING UP | +204.9% | +207.0% | +67.6% | +6.4% |
| DCAL | ₹149.70 | 145.3 | 0.6% | 9.0% | 21.0% | -50.1% | 55 | BOUNCE FROM SUPPORT | -347.9% | -367.3% | -4.2% | -20.4% |
| PANACEABIO | ₹345.20 | – | -1.1% | 10.1% | – | -17.9% | 49 | BOUNCE FROM SUPPORT | -42.5% | +360.0% | +19.7% | +19.7% |
| HALEOSLABS | ₹1,563.70 | 29.9 | 4.9% | 0.3% | 14.7% | +41.6% | 69 | BREAKOUT | -38.1% | +550.0% | -11.6% | -2.9% |
Data from TradeAlone · Updated daily
BLUEJET News
Blue Jet Healthcare Limited (BLUEJET) breaks below support, down 5%2026-08-03Blue Jet Healthcare Limited (BLUEJET) breaks out, gains 6% intraday2026-07-10Blue Jet Healthcare Limited (BLUEJET) gains 5% intraday2026-06-25Blue Jet Healthcare Limited Q4 & FY26 Earnings: Revenue Up 22%, PAT Increases by 60%2026-05-25
